Home/Pipeline/Live Biotherapeutic Product

Live Biotherapeutic Product

Non-alcoholic Fatty Liver Disease (NAFLD)

PreclinicalActive

Key Facts

Indication
Non-alcoholic Fatty Liver Disease (NAFLD)
Phase
Preclinical
Status
Active
Company

About Liveome

South Korean biotech developing precision microbiome diagnostics and therapeutics for metabolic diseases through advanced genomic analysis.

View full company profile

Therapeutic Areas

Other Non-alcoholic Fatty Liver Disease (NAFLD) Drugs

DrugCompanyPhase
ZED1227ZediraPhase 2a